Application Window Opens for LUNGevity Research Awards on January 8, 2024
LUNGevity Foundation
LUNGevity is transforming lung cancer through research, education, and support.
Research transforms the lives of those diagnosed with lung cancer. In 2024, LUNGevity is proud to continue our investments in the most promising lung cancer research. Read on for descriptions of some of the research programs offered this year and visit the LUNGevity website for details.?
?
Career Development Award Program: This program supports future research leaders who will keep the field of lung cancer research vibrant with?new ideas. Funded projects are expected to have a direct impact on the early detection of lung cancer or on the outcomes of lung cancer, or to provide a clear conceptual or experimental foundation for the future development of methods for early detection and/or individualized treatment, including through targeted therapy and immunotherapy.?
?
Hamoui Foundation/LUNGevity Clinical Research Award Program for RET-positive Lung Cancer: This award supports high-impact research that seeks to transform the future for people diagnosed with RET-positive lung cancer.? Projects funded through this program are expected to have a direct impact on the outcomes of patients with advanced RET-positive lung cancer, but innovative proposals that address other unmet needs in the RET-positive lung cancer space are also invited for submission.?
?
RETpositive/LUNGevity Translational Research Award Program for RET-positive Cancer: The goal of this award is to fund high-impact research that seeks to transform the future for patients diagnosed with RET-positive cancers by changing RET-positive cancers into a chronic or curable condition.? Proposals focusing on multiple types of RET-positive cancers or with a clear impact on multiple types of RET-positive cancers will be given priority.?
?
The first step in the application process, LOI submissions, will open on January 8, 2024.??